• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰各地淋巴瘤临床试验中地理障碍和患者代表性方面的不平等。

Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.

作者信息

Jones David A, Spencer Katie, Ramroth Johanna, Probert Jake, Roope Laurence S J, Shakir Rebecca, Broggio John, Burroughs Frank, Collins Graham P, Clarke Philip M, Wolstenholme Jane L, Cutter David J

机构信息

Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.

出版信息

Br J Haematol. 2025 Feb;206(2):531-540. doi: 10.1111/bjh.19907. Epub 2024 Nov 27.

DOI:10.1111/bjh.19907
PMID:39604053
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11829142/
Abstract

The distribution of trial site locations may lead to disparities in geographic access and affect patient representativeness in clinical trials. We utilised trial data covering 1993-2022 from the National Institute for Health and Care Research (NIHR) Open Data Platform, 2011 and 2021 English Census and geographic data and English individual-patient cancer registry data for patients diagnosed with lymphoma between 1997 and 2017. To assess representation, we compared patient age and sex between trial participants and the incident population. We mapped the distance and travel times of English lower layer super output areas (LSOAs) to their nearest research active NHS Trusts and assessed associations between distance and travel times and the geographic and sociodemographic characteristics of the LSOAs. Trial participants were younger than the incident population and more likely to be male. The closest NHS Trust to more than half of English LSOAs was not research active. Greater LSOA mean age, male percent, White British percent, rurality and coastal/border status were positively associated with distance and travel time (at prespecified p < 0.05 level), while greater deprivation was negatively associated. Female and older lymphoma patients in England are underrepresented in trials, with the latter facing a higher burden of geographic barriers.

摘要

试验地点的分布可能导致地理可及性方面的差异,并影响临床试验中患者的代表性。我们利用了来自国家卫生与保健研究机构(NIHR)开放数据平台的1993 - 2022年试验数据、2011年和2021年的英国人口普查数据与地理数据,以及1997年至2017年期间被诊断为淋巴瘤的患者的英国个体患者癌症登记数据。为了评估代表性,我们比较了试验参与者与发病群体之间的患者年龄和性别。我们绘制了英国低层超级输出区(LSOAs)到其最近的开展研究的国民保健服务信托机构的距离和出行时间,并评估了距离和出行时间与LSOAs的地理和社会人口特征之间的关联。试验参与者比发病群体更年轻,且更有可能为男性。超过一半的英国LSOAs距离最近的国民保健服务信托机构并非开展研究的机构。LSOA的平均年龄越大、男性比例越高、英国白人比例越高、乡村性和沿海/边境状态与距离和出行时间呈正相关(在预先设定的p < 0.05水平),而贫困程度越高则呈负相关。英国的女性和老年淋巴瘤患者在试验中的代表性不足,后者面临着更高的地理障碍负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/0890d12c5f7d/BJH-206-531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/92cacf962f7d/BJH-206-531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/4de1e632c843/BJH-206-531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/3b6273cfdeda/BJH-206-531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/0890d12c5f7d/BJH-206-531-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/92cacf962f7d/BJH-206-531-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/4de1e632c843/BJH-206-531-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/3b6273cfdeda/BJH-206-531-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13d6/11829142/0890d12c5f7d/BJH-206-531-g001.jpg

相似文献

1
Inequalities in geographic barriers and patient representation in lymphoma clinical trials across England.英格兰各地淋巴瘤临床试验中地理障碍和患者代表性方面的不平等。
Br J Haematol. 2025 Feb;206(2):531-540. doi: 10.1111/bjh.19907. Epub 2024 Nov 27.
2
Variation in geographic access to specialist inpatient hospices in England and Wales.英格兰和威尔士专业住院临终关怀机构地理可及性的差异。
Health Place. 2012 Jul;18(4):832-40. doi: 10.1016/j.healthplace.2012.03.009. Epub 2012 Apr 3.
3
Geographic Access Disparities to Clinical Trials in Diabetic Eye Disease in the United States.美国糖尿病眼病临床试验的地理可及性差异
Ophthalmol Retina. 2021 Sep;5(9):879-887. doi: 10.1016/j.oret.2020.12.006. Epub 2020 Dec 17.
4
Geographical disparities in access to cancer management and treatment services in England.英格兰癌症管理与治疗服务可及性方面的地理差异。
Health Place. 2016 Nov;42:11-18. doi: 10.1016/j.healthplace.2016.08.014. Epub 2016 Sep 8.
5
Age specific trends in mortality disparities by socio-economic deprivation in small geographical areas of England, 2002-2018: A retrospective registry study.2002 - 2018年英格兰小地理区域内社会经济剥夺导致的死亡率差异的年龄特异性趋势:一项回顾性登记研究。
Lancet Reg Health Eur. 2021 Jun 7;7:100136. doi: 10.1016/j.lanepe.2021.100136. eCollection 2021 Aug.
6
Variation in compulsory psychiatric inpatient admission in England: a cross-classified, multilevel analysis.英格兰强制精神科住院治疗的差异:一项交叉分类的多层次分析。
Lancet Psychiatry. 2017 Aug;4(8):619-626. doi: 10.1016/S2215-0366(17)30207-9. Epub 2017 Jun 21.
7
Association of environmental and socioeconomic indicators with serious mental illness diagnoses identified from general practitioner practice data in England: A spatial Bayesian modelling study.从英国全科医生实践数据中识别出的环境和社会经济指标与严重精神疾病诊断的关联:一项空间贝叶斯建模研究。
PLoS Med. 2022 Jun 30;19(6):e1004043. doi: 10.1371/journal.pmed.1004043. eCollection 2022 Jun.
8
Social determinants of health inequalities in early phase clinical trials in Northern England.英格兰北部早期临床试验中健康不平等的社会决定因素。
Br J Cancer. 2024 Sep;131(4):685-691. doi: 10.1038/s41416-024-02765-w. Epub 2024 Jun 24.
9
Analysis and Optimization of Equitable US Cancer Clinical Trial Center Access by Travel Time.基于旅行时间的美国癌症临床试验中心公平准入分析与优化
JAMA Oncol. 2024 May 1;10(5):652-657. doi: 10.1001/jamaoncol.2023.7314.
10
Differential patient travel distance and time to psoriasis clinical trial sites.不同患者前往银屑病临床试验点的旅行距离和时间。
Arch Dermatol Res. 2023 Oct;315(8):2359-2363. doi: 10.1007/s00403-023-02633-2. Epub 2023 May 11.

引用本文的文献

1
Are we ignoring sex differences in haematological malignancies? A call for improved reporting.我们是否忽视了血液系统恶性肿瘤中的性别差异?呼吁改进报告。
Br J Haematol. 2025 May;206(5):1315-1329. doi: 10.1111/bjh.20044. Epub 2025 Mar 23.

本文引用的文献

1
Sex and gender bias in chronic coronary syndromes research: analysis of studies used to inform the 2019 European Society of Cardiology guidelines.慢性冠状动脉综合征研究中的性别与性取向偏见:用于为2019年欧洲心脏病学会指南提供信息的研究分析。 (注:原文中“Sex and gender bias”直译为“性别与性取向偏见”,但结合语境这里可能是指“性别偏见”,若按此理解,译文可调整为:慢性冠状动脉综合征研究中的性别偏见:用于为2019年欧洲心脏病学会指南提供信息的研究分析。) 因原译文要求不能添加解释说明,所以先给出未调整后的译文供你参考,你可根据实际需求决定是否调整。)
Lancet Reg Health Eur. 2024 Aug 30;45:101041. doi: 10.1016/j.lanepe.2024.101041. eCollection 2024 Oct.
2
Gender inequity in cancer research leadership in Europe: Time to act.欧洲癌症研究领导领域的性别不平等:是时候采取行动了。
Eur J Cancer. 2023 Nov;194:113345. doi: 10.1016/j.ejca.2023.113345. Epub 2023 Sep 17.
3
Countering sex and gender bias in cardiovascular research requires more than equal recruitment and sex disaggregated analyses.在心血管研究中对抗性别偏见,需要的不仅仅是平等招募和按性别分类分析。
BMJ. 2023 Aug 30;382:e075031. doi: 10.1136/bmj-2023-075031.
4
Representation of the population in need for pivotal clinical trials in lymphomas.代表性的人群需要关键的临床试验中的淋巴瘤。
Blood. 2023 Aug 31;142(9):846-855. doi: 10.1182/blood.2023020052.
5
Underrepresentation of women in randomized controlled trials: a systematic review and meta-analysis.女性在随机对照试验中的代表性不足:系统评价和荟萃分析。
Trials. 2022 Dec 21;23(1):1038. doi: 10.1186/s13063-022-07004-2.
6
The impact of driving time on participation in colorectal cancer screening with sigmoidoscopy and faecal immunochemical blood test.驾驶时间对乙状结肠镜检查和粪便免疫化学血液检测结直肠癌筛查参与的影响。
Cancer Epidemiol. 2022 Oct;80:102244. doi: 10.1016/j.canep.2022.102244. Epub 2022 Aug 31.
7
Opportunities and counterintuitive challenges for decentralized clinical trials to broaden participant inclusion.去中心化临床试验扩大参与者纳入范围的机遇与反直觉挑战。
NPJ Digit Med. 2022 May 5;5(1):58. doi: 10.1038/s41746-022-00603-y.
8
Improving diversity in research and trial participation: the challenges of language.提高研究和试验参与的多样性:语言方面的挑战。
Lancet Public Health. 2021 Jul;6(7):e445-e446. doi: 10.1016/S2468-2667(21)00100-6.
9
Analysis of Female Enrollment and Participant Sex by Burden of Disease in US Clinical Trials Between 2000 and 2020.分析 2000 年至 2020 年美国临床试验中按疾病负担划分的女性入组和参与者性别。
JAMA Netw Open. 2021 Jun 1;4(6):e2113749. doi: 10.1001/jamanetworkopen.2021.13749.
10
Shifting research culture to address the mismatch between where trials recruit and where populations with the most disease live: a qualitative study.改变研究文化以解决试验招募地点与疾病负担最重人群居住地之间的不匹配问题:一项定性研究。
BMC Med Res Methodol. 2021 Apr 21;21(1):80. doi: 10.1186/s12874-021-01268-z.